BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22696308)

  • 1. Expression profiling shows differential molecular pathways and provides potential new diagnostic biomarkers for colorectal serrated adenocarcinoma.
    Conesa-Zamora P; García-Solano J; García-García F; Turpin Mdel C; Trujillo-Santos J; Torres-Moreno D; Oviedo-Ramírez I; Carbonell-Muñoz R; Muñoz-Delgado E; Rodriguez-Braun E; Conesa A; Pérez-Guillermo M
    Int J Cancer; 2013 Jan; 132(2):297-307. PubMed ID: 22696308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal serrated adenocarcinoma shows a different profile of oncogene mutations, MSI status and DNA repair protein expression compared to conventional and sporadic MSI-H carcinomas.
    García-Solano J; Conesa-Zamora P; Carbonell P; Trujillo-Santos J; Torres-Moreno D D; Pagán-Gómez I; Rodríguez-Braun E; Pérez-Guillermo M
    Int J Cancer; 2012 Oct; 131(8):1790-9. PubMed ID: 22287190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylome profiling reveals functions and genes which are differentially methylated in serrated compared to conventional colorectal carcinoma.
    Conesa-Zamora P; García-Solano J; Turpin Mdel C; Sebastián-León P; Torres-Moreno D; Estrada E; Tuomisto A; Wilce J; Mäkinen MJ; Pérez-Guillermo M; Conesa A
    Clin Epigenetics; 2015; 7(1):101. PubMed ID: 26388956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two histologically colorectal carcinomas subsets from the serrated pathway show different methylome signatures and diagnostic biomarkers.
    García-Solano J; Turpin MC; Torres-Moreno D; Huertas-López F; Tuomisto A; Mäkinen MJ; Conesa A; Conesa-Zamora P
    Clin Epigenetics; 2018 Nov; 10(1):141. PubMed ID: 30413173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-protein interaction networks and modules analysis for colorectal cancer and serrated adenocarcinoma.
    Yu H; Ye L; Wang J; Jin L; Lv Y; Yu M
    J Cancer Res Ther; 2015; 11(4):846-51. PubMed ID: 26881529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VE1 immunohistochemistry accurately detects BRAF V600E mutations in colorectal carcinoma and can be utilized in the detection of poorly differentiated colorectal serrated adenocarcinoma.
    Sajanti S; Sirniö P; Väyrynen JP; Tuomisto A; Klintrup K; Mäkelä J; Ristimäki A; Mäkinen MJ
    Virchows Arch; 2014 Jun; 464(6):637-43. PubMed ID: 24722974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis.
    Laiho P; Kokko A; Vanharanta S; Salovaara R; Sammalkorpi H; Järvinen H; Mecklin JP; Karttunen TJ; Tuppurainen K; Davalos V; Schwartz S; Arango D; Mäkinen MJ; Aaltonen LA
    Oncogene; 2007 Jan; 26(2):312-20. PubMed ID: 16819509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in gene expression profiling and biomarkers between histological colorectal carcinoma subsets from the serrated pathway.
    García-Solano J; Turpin-Sevilla MDC; García-García F; Carbonell-Muñoz R; Torres-Moreno D; Conesa A; Conesa-Zamora P
    Histopathology; 2019 Oct; 75(4):496-507. PubMed ID: 31025430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIF-1α expression and high microvessel density are characteristic features in serrated colorectal cancer.
    Tuomisto A; García-Solano J; Sirniö P; Väyrynen J; Pérez-Guillermo M; Mäkinen MJ; Conesa-Zamora P
    Virchows Arch; 2016 Oct; 469(4):395-404. PubMed ID: 27421843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal poorly differentiated neuroendocrine carcinomas and mixed adenoneuroendocrine carcinomas: insights into the diagnostic immunophenotype, assessment of methylation profile, and search for prognostic markers.
    La Rosa S; Marando A; Furlan D; Sahnane N; Capella C
    Am J Surg Pathol; 2012 Apr; 36(4):601-11. PubMed ID: 22314183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of programmed death ligand-1 (PD-L1) in colorectal serrated adenocarcinoma.
    Zhu H; Qin H; Huang Z; Li S; Zhu X; He J; Yang J; Yu X; Yi X
    Int J Clin Exp Pathol; 2015; 8(8):9351-9. PubMed ID: 26464688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
    Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
    Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma.
    Chang W; Gao X; Han Y; Du Y; Liu Q; Wang L; Tan X; Zhang Q; Liu Y; Zhu Y; Yu Y; Fan X; Zhang H; Zhou W; Wang J; Fu C; Cao G
    Gut; 2014 Sep; 63(9):1457-67. PubMed ID: 24173294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour budding and other prognostic pathological features at invasive margins in serrated colorectal adenocarcinoma: a comparative study with conventional carcinoma.
    García-Solano J; Conesa-Zamora P; Trujillo-Santos J; Mäkinen MJ; Pérez-Guillermo M
    Histopathology; 2011 Dec; 59(6):1046-56. PubMed ID: 22175885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of fascin expression in advanced colorectal cancer: an immunohistochemical study of colorectal adenomas and adenocarcinomas.
    Hashimoto Y; Skacel M; Lavery IC; Mukherjee AL; Casey G; Adams JC
    BMC Cancer; 2006 Oct; 6():241. PubMed ID: 17029629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa.
    Bianchini M; Levy E; Zucchini C; Pinski V; Macagno C; De Sanctis P; Valvassori L; Carinci P; Mordoh J
    Int J Oncol; 2006 Jul; 29(1):83-94. PubMed ID: 16773188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New role of the antidepressant imipramine as a Fascin1 inhibitor in colorectal cancer cells.
    Alburquerque-González B; Bernabé-García M; Montoro-García S; Bernabé-García Á; Rodrigues PC; Ruiz Sanz J; López-Calderón FF; Luque I; Nicolas FJ; Cayuela ML; Salo T; Pérez-Sánchez H; Conesa-Zamora P
    Exp Mol Med; 2020 Feb; 52(2):281-292. PubMed ID: 32080340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of TTK mutations in microsatellite-unstable colorectal cancer and evaluation of their effect on spindle assembly checkpoint.
    Niittymäki I; Gylfe A; Laine L; Laakso M; Lehtonen HJ; Kondelin J; Tolvanen J; Nousiainen K; Pouwels J; Järvinen H; Nuorva K; Mecklin JP; Mäkinen M; Ristimäki A; Ørntoft TF; Hautaniemi S; Karhu A; Kallio MJ; Aaltonen LA
    Carcinogenesis; 2011 Mar; 32(3):305-11. PubMed ID: 21163887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
    Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
    Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsatellite pathologic score does not efficiently identify high microsatellite instability in colorectal serrated adenocarcinoma.
    García-Solano J; Conesa-Zamora P; Carbonell P; Trujillo-Santos J; Torres-Moreno D; Rodriguez-Braun E; Vicente-Ortega V; Pérez-Guillermo M
    Hum Pathol; 2013 May; 44(5):759-65. PubMed ID: 23089493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.